Rigosertib Oral In Transfusion Dependent Lower Risk Myelodysplastic Syndromes (Lr-Mds): Optimization Of Dose And Rate Of Transfusion Independence (Ti) Or Transfusion Reduction (Tr) In A Single-Arm Phase 2 Study

BLOOD(2017)

引用 0|浏览6
暂无评分
摘要
Background:
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要